✦ LIBER ✦

Early achievement and maintenance of the therapeutic goals using velaglucerase alfa in type 1 Gaucher disease

✍ Scribed by D. Elstein; G.M. Cohn; N. Wang; M. Djordjevic; C. Brutaru; A. Zimran

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Achievement of Therapeutic Goals Over 2

✍ Deborah Elstein; Hadhami Ben Turkia; Madhulika Kabra; Pilar Giraldo; Marie-Franç 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 57 KB

A 7-year open-label study of clinical pa

✍ Elstein, Deborah; Cohn, Gabriel; Zahrieh, David; Crombez, Eric; Zimran, Ari 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 58 KB

A benchmark analysis of the achievement

✍ Neal Weinreb; John Taylor; Timothy Cox; John Yee; Stephan vom Dahl 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 218 KB 👁 1 views

49. Five-year safety and efficacy of vel

✍ Deborah Elstein; Ari Zimran; Gabriel M. Cohn; Kiran Bhirangi 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Safety and efficacy of long-term enzyme

✍ Elstein, Deborah; Giraldo, Pilar; Mehta, Atul; Pastores, Gregory; Rhead, William 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 367 KB

Safety and Efficacy of Velaglucerase Alf

✍ Ari Zimran; Madhulika Kabra; Pilar Giraldo; Marie-Françoise Ben Dridi; Deborah E 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 50 KB